Treatment Options on the Horizon for Glaucoma Management

Oral JAK Inhibitors May Displace Injectable Biologics in Treatment of Rheumatoid Arthritis

Patient Support Program Helps Sustain Low Disease Activity on TNF Inhibitor Therapy

bDMARDs Improve Vascular Function in Treatment-naïve Patients with Early Rheumatoid Arthritis

Early Knee, Jaw, Wrist, or Elbow Swelling Associated with Worse Rheumatoid Arthritis Prognosis

Once Stable, Many Decompensated Heart Failure Patients Can Be Initiated on Life-Saving Medication

JAK Inhibitors Test Specificity of Action in Rheumatoid Arthritis

Psoriatic Arthritis Remains Controlled on Anti-IL-17 Agents out to Three Years

Ensuring that All Heart Failure Patients Receive Optimal Treatment

In COPD, Large Percentage of Clinicians Ignore Evidence-based Guidelines

Phase 3 Trials of As-needed Anti-inflammatory Regimen Tested in Mild Asthma